ZIVO News and Press, Zivo Bioscience Inc. From 06/27/22

ZIVO Bioscience (NASDAQ:ZIVO) has joined the Russell Microcap® Index, effective from June 27, 2022. “Our inclusion reflects continued interest in our stock along with long- and near-term growth expectations as we evolve and execute on our business strategy.” stated John Pay...

ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”) , a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today announced that, effective today, June 27, 2022...

ZIVO Bioscience (NASDAQ:ZIVO) has regained compliance with Nasdaq Listing Rule 5250(c)(1). The company received a noncompliance notice Nasdaq last week for failing to timely file its 2021 annual report on Form 10-K with the SEC. It fully regained compliance on Apr. 22, 2022. For further det...

ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today announced that it received a Notice from Nasdaq tha...

Last year’s headlines (COVID-19 and China) have been replaced with new concerns (Invasions and Inflation). Central bankers are pivoting from stabilizing growth to limiting inflation. Traditional bond and equity markets have come under pressure as they adjust to this new regime....

Cyanotech is getting new wholesale orders for bulk microalgae production in Hawaii. Wall Street has not recognized the uptick in customer demand, or the possibility for stronger growth starting in 2022. The stock is incredibly undervalued and underfollowed today. Technical mom...

ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (“ZIVO” or the “Company”), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, announc...

ZIVO Bioscience is an R&D company operating in the biotech as well as the agritech sectors. The Company has an IP portfolio composed of proprietary algal and bacterial strains, biologically active molecules and complexes, with applications in human and animal health. Early stu...

Figs (NYSE:FIGS), Paymentus (NYSE:PAY) and several other companies that staged high-profile IPOs earlier this year will see their share lockups expire this coming week, offering possible catalysts for their price action. A big selloff or a lack thereof by insiders, pre-IPO investors and other...

NRx Pharmaceuticals (NASDAQ:NRXP) +36% on positive aviptadil data in Critical COVID-19 KORE Wireless (NYSE:KORE) +35%. TSR (NASDAQ:TSRI) +31% on Q1 earnings. Grove (NASDAQ:GRVI) +21 on launch of Amazon aggregation division Cemtrex (NASDAQ:CETX) +21%. Offerpad Solutions (NY...